277 related articles for article (PubMed ID: 18701717)
1. A Drosophila model for Angelman syndrome.
Wu Y; Bolduc FV; Bell K; Tully T; Fang Y; Sehgal A; Fischer JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12399-404. PubMed ID: 18701717
[TBL] [Abstract][Full Text] [Related]
2. The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches.
Lu Y; Wang F; Li Y; Ferris J; Lee JA; Gao FB
Hum Mol Genet; 2009 Feb; 18(3):454-62. PubMed ID: 18996915
[TBL] [Abstract][Full Text] [Related]
3. Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism.
Ferdousy F; Bodeen W; Summers K; Doherty O; Wright O; Elsisi N; Hilliard G; O'Donnell JM; Reiter LT
Neurobiol Dis; 2011 Mar; 41(3):669-77. PubMed ID: 21147225
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling in Drosophila reveals potential Dube3a regulation of the actin cytoskeleton and neuronal homeostasis.
Jensen L; Farook MF; Reiter LT
PLoS One; 2013; 8(4):e61952. PubMed ID: 23626758
[TBL] [Abstract][Full Text] [Related]
5. The E3 ligase ube3a is required for learning in Drosophila melanogaster.
Chakraborty M; Paul BK; Nayak T; Das A; Jana NR; Bhutani S
Biochem Biophys Res Commun; 2015 Jun; 462(1):71-7. PubMed ID: 25935478
[TBL] [Abstract][Full Text] [Related]
6. Glial overexpression of Dube3a causes seizures and synaptic impairments in Drosophila concomitant with down regulation of the Na
Hope KA; LeDoux MS; Reiter LT
Neurobiol Dis; 2017 Dec; 108():238-248. PubMed ID: 28888970
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide enhancer/suppressor screen for Dube3a interacting genes in Drosophila melanogaster.
Hope KA; McGinn A; Reiter LT
Sci Rep; 2019 Feb; 9(1):2382. PubMed ID: 30787400
[TBL] [Abstract][Full Text] [Related]
9. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
[TBL] [Abstract][Full Text] [Related]
10. The Drosophila melanogaster homolog of UBE3A is not imprinted in neurons.
Hope KA; LeDoux MS; Reiter LT
Epigenetics; 2016 Sep; 11(9):637-642. PubMed ID: 27599063
[TBL] [Abstract][Full Text] [Related]
11. Drosophila UBE3A regulates satiety signaling through the Piezo mechanosensitive ion channel.
Geier B; Neely L; Coronado E; Reiter LT
Res Sq; 2023 Jul; ():. PubMed ID: 37461494
[TBL] [Abstract][Full Text] [Related]
12. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
[TBL] [Abstract][Full Text] [Related]
13. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
[TBL] [Abstract][Full Text] [Related]
14. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
Reiter LT; Seagroves TN; Bowers M; Bier E
Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
[TBL] [Abstract][Full Text] [Related]
16. Understanding the pathogenesis of Angelman syndrome through animal models.
Jana NR
Neural Plast; 2012; 2012():710943. PubMed ID: 22830052
[TBL] [Abstract][Full Text] [Related]
17. Ube3a imprinting impairs circadian robustness in Angelman syndrome models.
Shi SQ; Bichell TJ; Ihrie RA; Johnson CH
Curr Biol; 2015 Mar; 25(5):537-45. PubMed ID: 25660546
[TBL] [Abstract][Full Text] [Related]
18. Towards an understanding of Angelman syndrome in mice studies.
Yang X
J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
[TBL] [Abstract][Full Text] [Related]
19. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
Mabb AM; Judson MC; Zylka MJ; Philpot BD
Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
[TBL] [Abstract][Full Text] [Related]
20. UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.
Elgersma Y; Sonzogni M
Dev Med Child Neurol; 2021 Jul; 63(7):802-807. PubMed ID: 33543479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
